The Draft Genome of Mycobacterium Aurum, a Potential Model Organism for Investigating Drugs Against Mycobacterium Tuberculosis and Mycobacterium Leprae

Total Page:16

File Type:pdf, Size:1020Kb

The Draft Genome of Mycobacterium Aurum, a Potential Model Organism for Investigating Drugs Against Mycobacterium Tuberculosis and Mycobacterium Leprae The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae Item Type Article Authors Phelan, Jody; Maitra, Arundhati; McNerney, Ruth; Nair, Mridul; Gupta, Antima; Coll, Francesc; Pain, Arnab; Bhakta, Sanjib; Clark, Taane G. Citation The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae 2015 International Journal of Mycobacteriology Eprint version Publisher's Version/PDF DOI 10.1016/j.ijmyco.2015.05.001 Publisher Medknow Journal International Journal of Mycobacteriology Rights Archived with thanks to International Journal of Mycobacteriology, Under a Creative Commons license, http:// creativecommons.org/licenses/by-nc-nd/4.0/ Download date 25/09/2021 10:36:51 Link to Item http://hdl.handle.net/10754/556900 International Journal of Mycobacteriology xxx (2015) xxx– xxx HOSTED BY Available at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IJMYCO The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and 5 Mycobacterium leprae Jody Phelan a,*, Arundhati Maitra b,1, Ruth McNerney a,1, Mridul Nair c, Antima Gupta b, Francesc Coll a, Arnab Pain c,2, Sanjib Bhakta b,2, Taane G. Clark a,d,2 a Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom b Mycobacteria Research Laboratory, Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck College, University of London, Malet Street, London WC1E 7HX, United Kingdom c Biological and Environmental Sciences and Engineering Division, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia d Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom ARTICLE INFO ABSTRACT Article history: Mycobacterium aurum (M. aurum) is an environmental mycobacteria that has previously Received 27 April 2015 been used in studies of anti-mycobacterial drugs due to its fast growth rate and low Accepted 3 May 2015 pathogenicity. The M. aurum genome has been sequenced and assembled into 46 contigs, Available online xxxx with a total length of 6.02 Mb containing 5684 annotated protein-coding genes. A phyloge- netic analysis using whole genome alignments positioned M. aurum close to Mycobac- Keywords: terium vaccae and Mycobacterium vanbaalenii, within a clade related to fast-growing Mycobacteria mycobacteria. Large-scale genomic rearrangements were identified by comparing the M. M. aurum aurum genome to those of Mycobacterium tuberculosis and Mycobacterium leprae. M. aurum M. tuberculosis orthologous genes implicated in resistance to anti-tuberculosis drugs in M. tuberculosis M. leprae were observed. The sequence identity at the DNA level varied from 68.6% for pncA (pyraz- Drug screening inamide drug-related) to 96.2% for rrs (streptomycin, capreomycin). We observed two Genome homologous genes encoding the catalase-peroxidase enzyme (katG) that is associated with resistance to isoniazid. Similarly, two embB homologues were identified in the M. aurum genome. In addition to describing for the first time the genome of M. aurum, this work pro- vides a resource to aid the use of M. aurum in studies to develop improved drugs for the pathogenic mycobacteria M. tuberculosis and M. leprae. Ó 2015 Production and hosting by Elsevier Ltd. on behalf of Asian African Society for Mycobacteriology. * Corresponding author at: Pathogen Molecular Biology Department, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom. Tel.: +44 (0) 20 7636 8636. E-mail address: [email protected] (J. Phela). 1 Joint authors. 2 Joint authors. Peer review under responsibility of Asian African Society for Mycobacteriology. http://dx.doi.org/10.1016/j.ijmyco.2015.05.001 2212-5531/Ó 2015 Production and hosting by Elsevier Ltd. on behalf of Asian African Society for Mycobacteriology. Please cite this article in press as: J Phelan et al. The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae. Int. J. Mycobacteriol. (2015), http://dx.doi.org/10.1016/j.ijmyco.2015.05.001 2 International Journal of Mycobacteriology xxx (2015) xxx– xxx Introduction raw sequence data (size 0.55 Gb, 5.5 million paired reads, available from ENA ERP009288, minimum base call accuracy Mycobacterium aurum (M. aurum) is an acid-fast, gram-positive greater than 99%) underwent de novo assembly using SPAdes environmental bacteria typically found in damp conditions software [19]. The SSPACE software [20] was applied to scaf- [1,2]. It is a fast-growing mycobacterium with an in vitro dou- fold the assembly, and a combination of IMAGE [21] and bling time of 2–3 h that rarely causes infections in humans [2– GapFiller [22] routines were used to further close or reduce 6]. The M. aurum cell wall contains mycolic acids which are the length of remaining gaps. An alternative approach using analogous to those found in Mycobacterium tuberculosis [7], Velvet assembly software [23] led to a near identical assembly. and there are similarities between the antibiotic susceptibility Genomic annotation was transferred to the draft genome profiles of the two organisms [8,9]. The fast growth rate and using the Prokka pipeline [24]. The pipeline searches for genes low pathogenicity of M. aurum have encouraged its use as a present in contigs and compares them with protein and DNA surrogate for the highly pathogenic M. tuberculosis in studies databases to annotate them. The cd-hit software [25,26] was of anti-microbial activity of anti-tubercular drugs [6,10,11]. used to integrate the annotation from 8 mycobacterial species Unlike other fast-growing mycobacteria, such as to create a non-redundant blast ‘‘primary’’ database used by Mycobacterium smegmatis, M. aurum has the ability to survive the Prokka pipeline. To validate the draft assembly and anno- within macrophages [12,13] and has been used for high tation pipeline, the transferred annotation was compared throughput intracellular drug screening, allowing assessment against the kas operon sequence (GenBank: DQ268649.2). All of the ability of compounds to permeate the cell membrane 5 genes from the GenBank entry (fabD, acpM, kasA, kasB, and their stability within the cell [14,15]. The emergence of accD6) were annotated in the correct order and orientation strains of M. tuberculosis resistant to multiple first- and in the assembly. second-line drugs threatens efforts to control tuberculosis (TB) and has renewed interest in the search for new anti- tubercular agents [16]. Rapid-growing models for screening Comparative genomics putative anti-tubercular compounds are needed to accelerate drug discovery studies. Similarly, surrogate bacteria are Genomes from 27 species used in whole genome compar- needed to enable studies on drugs that may improve treat- isons were downloaded from ensembl (bacteria.ensembl.org), ment for infection with non-culturable Mycobacterium leprae. and the Uniprot taxon identification numbers are listed in Knowledge of the bacterial genome could enhance under- Table 1. Gene multiple alignments were constructed using standing of the molecular basis for drug resistance, and to clustalw2 [27] for 16S rRNA and MACSE software [28] for this end, the genome of M. aurum has been sequenced and rpoB sequences. Raxml software [29] was used to construct annotated. The genome was placed in a mycobacterium phy- the best scoring maximum likelihood tree, which was rooted logeny, and comparisons with M. tuberculosis, M. leprae and M. using the Corynebacterium glutamicum (strain: ATCC 13032) smegmatis genomes were made in relation to susceptibility reference sequence, an organism closely related to the towards anti-tubercular drugs. mycobacterium genus [30]. Pairwise gene alignments were constructed using MACSE software, which uses the trans- Materials and methods lated amino acid sequence and accounts for frame shifts and premature stop codons. Sequence identities were calcu- M. aurum sample and DNA extraction lated using the SIAS webserver. Gaps were not used in the calculation of the percent identity. Whole genome align- The M. aurum (NCTC 10437) was grown in 7H9 Middlebrook ments were constructed using mercator and mavid programs broth (Becton Dickinson, USA) supplemented with 10% albu [31], and the resulting homology map was inspected and min–dextrose–catalase (ADC) at 35 °C. DNA was extracted drawn using CIRCOS [32]. Orthologue clusters were created using the Bilthoven RFLP protocol [17]. In brief, log phase using OrthoMCL [33]. To identify any protein coding genes growth bacteria were treated with lysozyme, sodium dodecyl under selective pressure across M. aurum, M. tuberculosis, sulphate, proteinase K, N-cetyl-N,N,N-trimethyl ammonium Mycobacterium bovis – BCG, M. smegmatis, and M. leprae, the bromide (CTAB) and chloroform-isoamyl alcohol prior to pre- Ka/Ks ratio was calculated, where Ka is the number of non- cipitation with isopropanol. Minimum inhibitory concentra- synonymous substitutions per non-synonymous site, and tion (MIC) values for ethambutol, isoniazid, pyrazinamide Ks is the number of synonymous substitutions per synony- and rifampicin drugs for the same M. aurum strain are avail-
Recommended publications
  • Heat-Killed M. Aurum Aogashima (Brand Name: Au+) Novel Food Ingredient Application
    Page 1 of 27 Heat-killed M. aurum Aogashima (Brand name: Au+) Novel food Ingredient Application By Solution Sciences Ltd. Page 2 of 27 1. Contents Table 1: Abbreviations ........................................................................................................................................ 3 Table 2: List of Annexes ...................................................................................................................................... 4 Table 3: List of References .................................................................................................................................. 5 1. Administrative Data .................................................................................................................................... 8 Notes on confidentiality .................................................................................................................................. 8 2. General Introduction and Description of Mycobacterium aurum Aogashima ............................................ 9 I The purpose of tHe novel food ingredient .............................................................................................. 9 3. Identification of essential information requirements ............................................................................... 11 4. Consultation of structured schemes ......................................................................................................... 12 I Structured ScHeme I: Specification of tHe Novel Food ingredient
    [Show full text]
  • Mycobacterium Austroafricanum Sp
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, July 1983, p. 460-469 Vol. 33, No. 3 0020-7713/83/030460-10$02.00/0 Copyright 0 1983, International Union of Microbiological Societies Numerical Taxonomy of Rapidly Growing, Scotochromogenic Mycobacteria of the Mycobacterium parafortuitum Complex: Mycobacterium austroafricanum sp. nov. and Mycobacterium diernhoferi sp. nov., nom. rev. MICHIO TSUKAMURA,’* HERMINA J. VAN DER MEULEN,2 AND WILHELM 0. K. GRABOW3 National Chubu Hospital, Obu, Aichi, Japan 474l: South African Institute for Medical Research, Johannesburg 2001, South Africa2; and National Institute for Water Research, Pretoria 0002, South Africa3 A numerical analysis of phenetic data collected from rapidly growing, scotoch- romogenic mycobacterial strains isolated from water in South Africa and from strains of the taxa Mycobacterium parafortuitum, Mycobacterium aurum, Myco- bacterium neoaurum, and “Mycobacterium diernhoferi” indicated that all of these organisms belong to the Mycobacterium parqfortuitum complex. Our results also indicated that each of the taxa mentioned above is worthy of species status within the complex. The name Mycobacterium austroafricanum sp. nov. is proposed for the South African isolates, and the characteristics of these isolates are described; the type strain is E9789-SA12441 (= ATCC 33464). The name Mycobacterium diernhoferi is revived for the organism described originally by Bonicke and Juhasz in 1965; the type strain of this species is strain 41001 (= ATCC 19340). Three species of rapidly growing, scotochro- at -20°C and were subcultured at 6-month intervals. mogenic mycobacteria, Mycobacterium para- Only the strains deposited in the American Type fortuitum (i6), Mycobacte&m aurum (7), and Culture Collection, Rockville, Md., are shown in Mycobacteriurn neoaurum (9), have not been Table 1.
    [Show full text]
  • Mycobacterium Brumae Sp
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, July 1993, p. 405-413 Vol. 43, No. 3 0020-7713/93/030405-09$02.00/0 Copyright 0 1993, International Union of Microbiological Societies Mycobacterium brumae sp. nov., a Rapidly Growing, Nonphotochromogenic Mycobacterium M. LUQUIN,132*V. AUSINA,1,2 V. VINCENT-LEVY-FREBAULT,3 M. A. LvEELLE,4 F. BELDA,172 M. GARCiA-BARCEL0,172G. PRATS,' AND M. DAFFE4 Servicio de Microbiologia, Hospital de la Santa Cruz y San Pablo, Departamento de Genttica y Microbiolog*a, Universidad Autbnoma de Barcelona, 08025 Barcelona, ' and Servicio de Microbiolog'a, Hospital Germans Trias i Pujol, Departamento de Genetica y Microbiolog'a, Universidad Autonoma de Barcelona, 08915 Badalona, Spain, and Unite de la Tuberculose et des Mycobactkries, Institut Pasteur, 75724 Paris Cedex 15,3 and Departement III du LPTF du Centre National de la Recherche Scientifque et Universitk Paul Sabatier, 31062 Toulouse Ceda, France Strains of a new species of rapidly growing, nonphotochromogenic mycobacteria, Mycobacterium brumae, have been isolated from water, soil, and human sputum samples in Barcelona, Spain. The inclusion of this organism in the genus Mycobacterium is based on its acid-alcohol fastness, its DNA G+C content, its mycolate pattern, and its mycolate pyrolysis esters. A study of 11 strains showed that they form a homogeneous group with an internal phenotypic similarity value of 94.9 +, 3.7%. The results of a comparison with 39 other mycobacterial species and subspecies are also presented. DNA relatedness studies showed that the M. brumae strains studied form a single DNA hybridization group which is less than 30% related to 15 other species of the genus Mycobacterium.
    [Show full text]
  • The Impact of Chlorine and Chloramine on the Detection and Quantification of Legionella Pneumophila and Mycobacterium Spp
    The impact of chlorine and chloramine on the detection and quantification of Legionella pneumophila and Mycobacterium spp. Maura J. Donohue Ph.D. Office of Research and Development Center of Environmental Response and Emergency Response (CESER): Water Infrastructure Division (WID) Small Systems Webinar January 28, 2020 Disclaimer: The views expressed in this presentation are those of the author and do not necessarily reflect the views or policies of the U.S. Environmental Protection Agency. A Tale of Two Bacterium… Legionellaceae Mycobacteriaceae • Legionella (Genus) • Mycobacterium (Genus) • Gram negative bacteria • Nontuberculous Mycobacterium (NTM) (Gammaproteobacteria) • M. avium-intracellulare complex (MAC) • Flagella rod (2-20 µm) • Slow grower (3 to 10 days) • Gram positive bacteria • Majority of species will grow in free-living • Rod shape(1-10 µm) amoebae • Non-motile, spore-forming, aerobic • Aerobic, L-cysteine and iron salts are required • Rapid to Slow grower (1 week to 8 weeks) for in vitro growth, pH: 6.8 to 7, T: 25 to 43 °C • ~156 species • ~65 species • Some species capable of causing disease • Pathogenic or potentially pathogenic for human 3 NTM from Environmental Microorganism to Opportunistic Opponent Genus 156 Species Disease NTM =Nontuberculous Mycobacteria MAC = M. avium Complex Mycobacterium Mycobacterium duvalii Mycobacterium litorale Mycobacterium pulveris Clinically Relevant Species Mycobacterium abscessus Mycobacterium elephantis Mycobacterium llatzerense. Mycobacterium pyrenivorans, Mycobacterium africanum Mycobacterium europaeum Mycobacterium madagascariense Mycobacterium rhodesiae Mycobacterium agri Mycobacterium fallax Mycobacterium mageritense, Mycobacterium riyadhense Mycobacterium aichiense Mycobacterium farcinogenes Mycobacterium malmoense Mycobacterium rufum M. avium, M. intracellulare, Mycobacterium algericum Mycobacterium flavescens Mycobacterium mantenii Mycobacterium rutilum Mycobacterium alsense Mycobacterium florentinum. Mycobacterium marinum Mycobacterium salmoniphilum ( M. fortuitum, M.
    [Show full text]
  • Bacteremia Caused by Mycobacterium Neoaurum MALCOLM B
    JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1988, p. 762-764 Vol. 26, No. 4 0095-1137/88/040762-03$02.00/0 Copyright © 1988, American Society for Microbiology Bacteremia Caused by Mycobacterium neoaurum MALCOLM B. DAVISON,' JOSEPH G. McCORMACK,1* ZETA M. BLACKLOCK,2 DAVID J. DAWSON,2 MARTYN H. TILSE,3 AND FRANCIS B. CRIMMINS' Department of Medicine, University of Queensland, Mater Misericordiae Hospital, South Brisbane, Queensland 4101,' and Tuberculosis Laboratory, Laboratory of Microbiology and Pathology,2 and Department ofMicrobiology,3 Downloaded from Mater Misericordiae Adult Hospital, Brisbane, Queensland, Australia Received 18 September 1987/Accepted 14 December 1987 An immunocompromised patient with an indwelling Hickman catheter developed Mycobacterium neoaurum bacteremia. This rapidly growing mycobacterium was previously isolated from soil, dust, and water but has not been described as a human pathogen. The infection responded to therapy with cefoxitin and gentamicin. It was not necessary to remove the Hickman catheter. http://jcm.asm.org/ The first convincing evidence that mycobacteria other ethambutol per ml but not on MacConkey agar. Tests for than tubercle bacilli (MOTT) are potential pathogens was niacin production and p-aminosalicylate degradation were provided by Timpe and Runyon in 1954 (13). Since then, negative, while tests for nitrate reduction, Tween 80 hydrol- there has been increasing interest in their importance as the ysis (10 days), arylsulfatase (14 days), and iron uptake were causative agents of a variety of conditions, particularly in positive. Catalase activity was low. Glucose, fructose, ino- immunocompromised patients. The list of potential patho- sitol, and mannitol were utilized as carbon sources; sodium gens continues to grow.
    [Show full text]
  • Utilization of Molecular and Conventional Methods for the Identification of Nontuberculous Mycobacteria Isolated from Different Water Sources
    [Downloaded free from http://www.ijmyco.org on Monday, June 4, 2018, IP: 200.41.178.226] Original Article Utilization of Molecular and Conventional Methods for the Identification of Nontuberculous Mycobacteria Isolated from Different Water Sources Claudia Andrea Tortone1, Martín José Zumárraga2, Andrea Karina Gioffré2, Delia Susana Oriani1 1Laboratory of Mycobacteria, Faculty of Veterinary Sciences, National University of La Pampa, General Pico, La Pampa, 2Biotechnology Institute, National Institute of Agricultural Technology (INTA), Hurlingham, Buenos Aires, Argentina Abstract Background: The environment is the nontuberculous mycobacteria (NTM) reservoir, opportunistic pathogens of great diversity and ubiquity, which is observed in the constant description of new species capable of causing infection. Since its introduction, molecular methods are essential for species identification. Most comparative studies between molecular and conventional methods, have used isolated strains from clinical samples. Methods: The aim of this study was to evaluate the usefulness of molecular methods, especially the hsp65‑PRA (PCR‑Restriction Enzyme Analysis), and biochemical tests in the identification of NTM recovered from water of different origins, using the sequencing of 16S rRNA and hsp65 genes as assessment methods of the previous ones. Species identification was performed for all 56 NTM isolates what were recovered from 32 (42.1%) positive water samples, using conventional phenotypic methods, hsp65‑PRA, partial sequencing of 16S rRNA and sequencing
    [Show full text]
  • Mycobacterial Infection in Farmed Turbot Scophthalmus Maximus
    DISEASES OF AQUATIC ORGANISMS Vol. 52: 87–91, 2002 Published November 7 Dis Aquat Org NOTE Mycobacterial infection in farmed turbot Scophthalmus maximus N. M. S. dos Santos1, 2,*, A. do Vale1, M. J. Sousa3, M. T. Silva1 1Institute for Molecular and Cell Biology, Rua do Campo Alegre no. 823, 4150-180 Porto, Portugal 2Novartis Animal Vaccines Ltd, 4 Warner Drive, Springwood Industrial Estate, Braintree, Essex CM7 2YW, United Kingdom 3Instituto Nacional de Saúde Dr. Ricardo Jorge, Laboratório de Tuberculose e Micobactérias, Largo 1º de Dezembro, 4000 Porto, Portugal ABSTRACT: Mycobacteriosis (piscine tuberculosis) has been kidney and liver (Frerichs 1993, Belas et al. 1995). reported to affect a wide range of freshwater and marine fish Mycobacterium marinum, M. fortuitum and M. che- species; however, this is the first report describing mycobac- lonae are the most common species found in fish terial infections in turbot Scophthalmus maximus. High num- bers of granulomas were initially observed in the organs of (Frerichs 1993, Belas et al. 1995). Recently, 2 new moribund farmed turbot. Bacteriological analysis of organs mycobacterium species infecting fish have been pro- with granulomas led to the isolation of Mycobacterium mar- posed (Heckert et al. 2001, Herbst et al. 2001). In addi- inum. Further analysis, to determine the prevalence of the tion, M. marinum, M. fortuitum and M. chelonae have infection in the farm and to identify its source, showed the occurrence of a dual infection by M. marinum and M. che- been reported as being capable of infecting warm- lonae. The presence of Nocardia sp. in some of the fish blooded vertebrates, including man (Frerichs 1993).
    [Show full text]
  • Prevalence of the Gene Lsr2 Among the Genus Mycobacterium and an Investigation Into Changes in Biofilm Formation When Inactivat
    Prevalence of the gene lsr2 among the genus Mycobacterium and an investigation into changes in biofilm formation when inactivating lsr2 regulated genes in Mycobacterium smegmatis A Thesis SUBMITTED TO THE FACULTY OF UNIVERSITY OF MINNESOTA BY Wayne C. Gatlin III IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE John L. Dahl October, 2014 © Wayne Gatlin 2014 i Acknowledgements I would like to express my heartfelt thanks to my advisor Dr. John L. Dahl, whose guidance and sense of wonder invigorated my own scientific curiosities. Dr. Dahl showed me how science can be a multidisciplinary experience that feeds off all forms of the arts. I would also like to thank Dr. Dahl for showing me how to be a good teacher, of which he is the gold standard. ii Abstract There are many Mycobacterium species found throughout the world, some capable of causing human disease or industrial problems. Mycobacterium tuberculosis is arguably the most infamous, however, there are over 150 other species of Mycobacterium that have also been identified. Many mycobacterium are capable of forming biofilms, which are complex matrixes of bacterial cells that can adhere to surfaces. Recently, a strain of Mycobacterium smegmatis was characterized that lacked the ability to form biofilms. This phenotype has been linked to a mutation leading to the absence of the DNA bridging protein Lsr2. This study describes the further characterization of the role the lsr2 gene plays in biofilm formation in M. smegmatis and the prevalence of the gene among other species of the genus Mycobacterium. This study reports that lsr2 is found in 46 of 52 Mycobacterial species tested.
    [Show full text]
  • Susceptibility and Resistance Data
    toku-e logo For a complete list of references, please visit antibiotics.toku-e.com Isoniazid Microorganism Genus, Species, and Strain (if shown) Concentration Range (μg/ml)Susceptibility and Mycobacteria ? Minimum- ? Inhibitory Mycobacterium aurum >256 - ? Mycobacterium aurum (ATCC 23366) Concentration0.06 - ? (MIC) Data Mycobacterium aurum (Pasteur Institute 104482) 2 - ? Issue date 01/06/2020 Mycobacterium avium ? - ? Mycobacterium avium (ATCC 19421) 100 - ? Mycobacterium avium (NIHJ 1605) 1 - ? Mycobacterium bovis (ATCC 19210) 0.25 - ? Mycobacterium bovis (BCG + kas(A)) 0.07 - ? Mycobacterium bovis (BCG + kas(AB)) 0.05 - ? Mycobacterium bovis (BCG + kas(B)) 0.05 - ? Mycobacterium bovis (BCG) 0.06 - ? Mycobacterium chelonae (ATCC 14472) >32 - ? Mycobacterium fortuitum 0.25 - ? Mycobacterium fortuitum (ATCC 6841) 0.5 - ? Mycobacterium fortuitum (ATCC 6841) 0.5 - ? Mycobacterium fortuitum (ATCC 6841) 2 - ? Mycobacterium fortuitum (clinical isolate) 2 - ? Mycobacterium gordonae 8 - ? Mycobacterium intracellulare ? - ? Mycobacterium intracellulare (ATCC 1954 E-3) 8 - ? Mycobacterium kansasii (ATCC 12478) 2 - ? Mycobacterium kansasii (clinical isolate) 4 - ? Mycobacterium paratuberculosis (ATCC 27294 + H38Rv + isoniazid-susceptible + rifampin-su) 0.025 - 0.05 Mycobacterium phlei 2 - ? Mycobacterium phlei 4 - ? Mycobacterium phlei (ATCC 11758) 2 - ? Mycobacterium scrofulaceum (ATCC 19981) 0.5 - ? Mycobacterium scrofulaceum (clinical isolate) 2 - ? Mycobacterium smegmatis (ATCC 14468) 2 - ? Mycobacterium smegmatis (ATCC 14468) 8 - ? Mycobacterium
    [Show full text]
  • Efflux Pump Inhibitors Against Nontuberculous Mycobacteria
    International Journal of Molecular Sciences Review Efflux Pump Inhibitors against Nontuberculous Mycobacteria Laura Rindi Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Università di Pisa, I-56127 Pisa, Italy; [email protected]; Tel.: +39-050-2213-688; Fax: +39-050-2213-682 Received: 28 May 2020; Accepted: 10 June 2020; Published: 12 June 2020 Abstract: Over the last years, nontuberculous mycobacteria (NTM) have emerged as important human pathogens. Infections caused by NTM are often difficult to treat due to an intrinsic multidrug resistance for the presence of a lipid-rich outer membrane, thus encouraging an urgent need for the development of new drugs for the treatment of mycobacterial infections. Efflux pumps (EPs) are important elements that are involved in drug resistance by preventing intracellular accumulation of antibiotics. A promising strategy to decrease drug resistance is the inhibition of EP activity by EP inhibitors (EPIs), compounds that are able to increase the intracellular concentration of antimicrobials. Recently, attention has been focused on identifying EPIs in mycobacteria that could be used in combination with drugs. The aim of the present review is to provide an overview of the current knowledge on EPs and EPIs in NTM and also, the effect of potential EPIs as well as their combined use with antimycobacterial drugs in various NTM species are described. Keywords: efflux pump inhibitor; nontuberculous mycobacteria; drug resistance; Mycobacterium avium complex; Mycobacterium abscessus 1. Introduction Infections by nontuberculous mycobacteria (NTM) represent a relevant problem for human health in many countries in the world. NTM, consisting of all Mycobacterium species except for Mycobacterium tuberculosis complex and Mycobacterium leprae, are a group of over 180 environmental species, generally endowed with low pathogenicity to humans [1,2].
    [Show full text]
  • Characterisation of a Putative Serine Protease Expressed in Vivo by Mycobacterium Avium Subsp
    Characterisation of a Putative Serine Protease Expressed in vivo by Mycobacterium avium subsp. paratuberculosis. Rona Mary Cameron Presented for the degree of PhD The University of Edinburgh 1996 a Table of Contents. Declaration .................................................................................................... Aknowledgements ..........................................................................................ii Abstract ......................................................................................................... Abbreviations ................................................................................................v Chapter 1 Introduction 1.1 The Mycobacterwceae ........................................................................1 1.1.1 The Cell Wall of Mycobacteria .............................................................1 1. 1.2 Mycobacterial Pathogens and Diseases .................................................. 5 1.2 The M. avium Complex (MAC) .......................................................... 6 1 .2.1 Members of the MAC ..........................................................................6 1.2.2 Molecular Characterisation of the MAC ................................................7 1 .2.3 Taxonomy of the MAC ........................................................................16 1.3 Known Genes and Proteins of M.a. avium, M.a. sil;'aticum and M.a. paratuberculosis ................................................................................... 19 1.4 Johne's Disease
    [Show full text]
  • Synthesis, Anti-Infective Evaluation, Cytotoxicity, and in Silico Studies
    Supporting Information Substituted N-(Pyrazin-2-yl)benzenesulfonamides; Synthesis, Anti-infective Evaluation, Cytotoxicity, and In Silico Studies. Ghada Bouz 1,*, Martin Juhás 1, Lluis Pausas Otero 1, Cristina Paredes de la Red 1, Ondřej Janďourek 1, Klára Konečná 1, Pavla Paterová 2, Vladimír Kubíček 1, Jiří Janoušek 1, Martin Doležal 1 and Jan Zitko 1,* 1 Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic; [email protected] (M.J.); [email protected] (L.P.O.); [email protected] (C.P.R.); [email protected] (O.J.); [email protected] (K.K.); [email protected] (V.K.); [email protected] (J.J.); [email protected] (M.D.) 2 Department of Clinical Microbiology, University Hospital, Sokolská 581, 500 05 Hradec Králové, Czech Republic; [email protected] * Correspondence: [email protected] (G.B.); [email protected] (J.Z.); Tel.: +420-495-067-275 (G.B.); +420-495-067-272 (J.Z.) Biological assays In Vitro Activity Evaluation Against Mycobacterium Tuberculosis, Mycobacterium Kansasii, and Mycobacterium Avium A 96-well plate microdilution broth method was performed as described in Reference [1]. Tested strains Mycobacterium tuberculosis H37Rv CNCTC My 331/88 (ATCC 27294), M. kansasii CNCTC My 235/80 (ATCC 12478), and M. avium ssp. avium CNCTC My 80/72 (ATCC 15769) were obtained from the Czech National Collection of Type Cultures (CNCTC), National Institute of Public Health (Prague, Czech Republic). Middlebrook 7H9 broth of declared pH = 6.6 (Sigma-Aldrich) enriched with 0.4% of glycerol (Sigma-Aldrich) and 10% of OADC growth supplement (oleic acid, albumin, dextrose, catalase; Himedia, Mumbai, India) was used for cultivation.
    [Show full text]